These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30629692)

  • 1. Blood inflammatory and endothelial markers in women with von Willebrand disease.
    Govorov I; Bremme K; Larsson A; Holmström M; Komlichenko E; Chaireti R; Mints M
    PLoS One; 2019; 14(1):e0210544. PubMed ID: 30629692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation during a regular menstrual cycle in women with von Willebrand disease.
    Govorov I; Bremme K; Lindahl TL; Holmström M; Komlichenko E; Chaireti R; Mints M
    Sci Rep; 2018 Nov; 8(1):17467. PubMed ID: 30504807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Function in Patients With Von Willebrand Disease.
    Noone S; Schubert R; Fichtlscherer S; Hilberg T; Alesci S; Miesbach W
    Clin Appl Thromb Hemost; 2021; 27():1076029620984546. PubMed ID: 33448867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease.
    Blann AD; Nitu-Whalley IC; Lee CA; Lip GY
    Am J Hematol; 2002 Feb; 69(2):135-7. PubMed ID: 11835351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
    Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
    Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
    Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
    Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory and endothelial markers during the menstrual cycle.
    Chaireti R; Lindahl TL; Byström B; Bremme K; Larsson A
    Scand J Clin Lab Invest; 2016; 76(3):190-4. PubMed ID: 26963835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle.
    Chaireti R; Gustafsson KM; Byström B; Bremme K; Lindahl TL
    Hum Reprod; 2013 Jul; 28(7):1846-52. PubMed ID: 23592222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer.
    Mills PJ; Ancoli-Israel S; Parker B; Natarajan L; Hong S; Jain S; Sadler GR; von Känel R
    Brain Behav Immun; 2008 Jan; 22(1):98-104. PubMed ID: 17706918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble adhesion molecules in serum throughout the menstrual cycle.
    Bonello N; Norman RJ
    Hum Reprod; 2002 Sep; 17(9):2272-8. PubMed ID: 12202413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of the laboratory identification of von Willebrand disease in women.
    Kouides PA
    Semin Thromb Hemost; 2006 Jul; 32(5):480-4. PubMed ID: 16862520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
    Castaman G; Tosetto A; Federici AB; Rodeghiero F
    Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women prefer proactive support from providers for treatment of heavy menstrual bleeding: A qualitative study in adult women with moderate or severe Von Willebrand disease.
    Eising HP; Sanders YV; de Meris J; Leebeek FWG; Meijer K
    Haemophilia; 2018 Nov; 24(6):950-956. PubMed ID: 29989261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients.
    Selvam SN; Casey LJ; Bowman ML; Hawke LG; Longmore AJ; Mewburn J; Ormiston ML; Archer SL; Maurice DH; James P
    Blood Coagul Fibrinolysis; 2017 Oct; 28(7):521-533. PubMed ID: 28362648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand disease and bleeding in women.
    Ragni MV; Bontempo FA; Hassett AC
    Haemophilia; 1999 Sep; 5(5):313-7. PubMed ID: 10583512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of von Willebrand disease in women with iron deficiency anaemia and menorrhagia in Taiwan.
    Chen YC; Chao TY; Cheng SN; Hu SH; Liu JY
    Haemophilia; 2008 Jul; 14(4):768-74. PubMed ID: 18498402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.
    Delbrück C; Miesbach W
    Acta Haematol; 2019; 142(2):71-78. PubMed ID: 31085919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.